A clinical trial shows convincingly that a combination of two classes of drugs is superior to current treatments for osteoporosis, and increases bone density.
UCSF invites the public to attend "Stem Cell Research: Implications for the Future," a discussion among leading stem cell scientists and Nobel laureates, on Tuesday, Sept. 20, from 7:30 to 9 p.m., at UCSF's Mission Bay campus. Reservations are required.
Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.
The campus community is invited to a free seminar on the new nuclear danger --considered by some to be the supreme threat to human health and welfare -- tomorrow, Aug. 11 at UCSF.
Postmenopausal women who took a bone-building drug for one year followed by a year on a standard drug that fights bone loss experienced greater increases in bone density than has been reported from any other drug regimen, an NIH-sponsored study has found.
Patients suffering from a stroke are more likely to have improved outcomes and fewer complications when hospitals use standardized guidelines for stroke care during a patient's admission and discharge from the hospital, according to a study led by researchers at UCSF Medical Center.
Many people lose their hearing as they get older and turn to a hearing aid for help. Too often, however, the device doesn't meet expectations and use is discontinued, along with complaints that it was not helping enough.